BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 34171378)

  • 1. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.
    Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A
    Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.
    Mashouri L; Yousefi H; Aref AR; Ahadi AM; Molaei F; Alahari SK
    Mol Cancer; 2019 Apr; 18(1):75. PubMed ID: 30940145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes and their role in tumorigenesis and anticancer drug resistance.
    Milman N; Ginini L; Gil Z
    Drug Resist Updat; 2019 Jul; 45():1-12. PubMed ID: 31369918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
    Jena BC; Mandal M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional roles of exosomal long non-coding RNAs in cancer.
    Wang M; Zhou L; Yu F; Zhang Y; Li P; Wang K
    Cell Mol Life Sci; 2019 Jun; 76(11):2059-2076. PubMed ID: 30683984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.
    Lobb RJ; van Amerongen R; Wiegmans A; Ham S; Larsen JE; Möller A
    Int J Cancer; 2017 Aug; 141(3):614-620. PubMed ID: 28445609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Roles of Exosomes as EMT Regulators in Cancer.
    Kim H; Lee S; Shin E; Seong KM; Jin YW; Youn H; Youn B
    Cells; 2020 Apr; 9(4):. PubMed ID: 32252322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communication in tiny packages: Exosomes as means of tumor-stroma communication.
    Daßler-Plenker J; Küttner V; Egeblad M
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188340. PubMed ID: 31926290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis.
    Malla R; Puvalachetty K; Vempati RK; Marni R; Merchant N; Nagaraju GP
    Clin Breast Cancer; 2022 Aug; 22(6):507-514. PubMed ID: 35688785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.
    Santos P; Almeida F
    Cells; 2020 Jun; 9(6):. PubMed ID: 32545155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma.
    Zhang J; Song Q; Wu M; Zheng W
    Curr Med Chem; 2021; 28(1):93-109. PubMed ID: 32000636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
    Sundararajan V; Sarkar FH; Ramasamy TS
    Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications.
    da Costa VR; Araldi RP; Vigerelli H; D'Ámelio F; Mendes TB; Gonzaga V; Policíquio B; Colozza-Gama GA; Valverde CW; Kerkis I
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.
    Azmi AS; Bao B; Sarkar FH
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):623-42. PubMed ID: 23709120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the emerging role of exosome in hepatocellular carcinoma.
    Abudoureyimu M; Zhou H; Zhi Y; Wang T; Feng B; Wang R; Chu X
    Cell Prolif; 2019 Mar; 52(2):e12541. PubMed ID: 30397975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.